Description
Cell Line Information:
Designations: NCI-N87
Depositors: J Park
Growth Properties: adherent
Organism: Homo sapiens
Morphology: epithelial
Source: stomach
Disease: gastric carcinoma
Derived from metastatic site: liver
Isolation date: 1976
Receptors: acetylcholine, muscarinic, expressed [23078]
Tumorigenic: Yes
Oncogene: myc; erb B2
Cytogenetic Analysis: near diploid; DM were present in 64% of cells examined
Gender: male
Comments: NCI-N87 cells express the surface glycoproteins carcinoembryonic antigen (CEA) and TAG 72, and are L-dopa decarboxylase (DDC) negative. They were minimally positive for vasoactive intestinal peptide (VIP) receptors and lacked gastrin receptors. They were found to express receptors for muscarinic cholinergic agents.
The Transfection Reagent:
NCI-N87 Cell Avalanche™ Transfection Reagent is a new class of unique chemical formulations specifically formulated and optimized for transfecting NCI-N87 Cells. The proprietary formulation of lipids and polymers ensures the highest possible transfection efficiencies and viabilities for NCI-N87 Cells. For details of the developing process of this reagent, please go to: How did EZ Biosystems develop Avalanche™ Cell type/cell line specific transfection reagent series?
Features:
- Unique formulation-maximize transfection performance in NCI-N87 Cells.
- Extremely gentle to cells
- Deliver single or multiple plasmids
- Simplest and straightforward protocols
- Compatible with serum
- Suitable for Reverse Transfection
- Compatible with transfection in any plate formats
- Economical: High efficiency means less amount of nucleic acid & reagent is needed
- Developed and manufactured by EZ Biosystems
Data: | |||
| |||
For Other Cells: | |||
NCI-N87 Cell Avalanche™ Transfection Reagent (human gastric carcinoma cell) can also be used on the following cells with high transfection efficiencies. AGS Cell |
If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200